Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07835555 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation Trial

Name: Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation Trial — clinical trial record (NCT07835555)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 4

SponsorYale University

Started2027-09-30

View on ClinicalTrials.gov ↗

Yale University

487 trials monitored

See 35 trials at risk

Cigarette smoking is an important cause of illness and death among persons with HIV (PWH). This project will study the impact of adding contingency management (use of financial rewards) to receiving medications and counseling on promoting smoking abstinence and other health outcomes among PWH. As treatments will be provided by clinical pharmacists and other team members in HIV clinics, factors relevant for implementing this model to inform real-world practice will also be evaluated.

Trial Details

NCT Number	NCT07835555
Lead Sponsor	Yale University Collaborators: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions	Tobacco Use Disorder/Cigarette Smoking, HIV
Enrollment	794 participants
Start Date	2027-09-30
Primary Completion	2030-09-30 (estimated)
Study Completion	2031-09-30 (estimated)
Updated on ClinicalTrials.gov	2026-09-23